Prothena Corporation plc (Nasdaq: PRTA) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel antibodies that are directed towards diseases that involve protein misfolding or cell adhesion. prothena/ They have enough money to last years, yet they are making another offering for more cash!!! And, they are a possible candidate for tax inversion being based in Ireland. I did not like Elan and I am not familiar with their science, but they are now CASH HEAVY. [GF: https://google/finance?q=NASDAQ%3APRTA] Prothena Announces Proposed Offering of Ordinary Shares ir.prothena/releasedetail.cfm?ReleaseID=856111 DUBLIN, Ireland, June 23, 2014 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq: PRTA), a clinical stage biotechnology company focused on the discovery, development and commercialization of novel antibodies for the potential treatment of diseases that involve protein misfolding or cell adhesion, announced today that it has commenced an underwritten public offering of $100 million of its ordinary shares. All of the ordinary shares in the offering are to be sold by Prothena. In addition, Prothena has granted the underwriters a 30-day option to purchase up to an additional $15 million of its ordinary shares.
Posted on: Tue, 24 Jun 2014 13:01:58 +0000
Trending Topics
Recently Viewed Topics
© 2015